Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05483426

Prevalence of Sexual Addiction in an Inmate Population at the Muret Detention Center in Haute-Garonne (PAS-CD)

Sexual addiction, also known as hypersexuality or compulsive sexuality, is a human sexual behavior that results in a continuous and persistent search for sexual pleasure. Replacing the former terms satyriasis and nymphomania, the World Health Organization (WHO) ICD-11 has referred to this disorder as "compulsive sexual behavior disorders".

From multiple causes (iatrogeny, neurological causes, psychiatric causes, psychopathological hypotheses), but still only partially known, the inclusion of this disorder among impulsivity-related disorders, obsessive-compulsive disorders or addiction-related disorders is still debated in the scientific literature. Thus, in the absence of sufficient robust scientific data, DSM-5 refused to include this disorder in its classification.

However, the consequences of this disorder on the psychosocial functioning of individuals are not negligible, which can go as far as the precipitation of a transition to an heteroaggressive act which can thus lead to incarceration.

The prevalence of this disorder in the general population is estimated between 2 and 6% based on current literature data. This rate appears to be higher among men and more specifically among sex offenders.

However, some authors have noted that the difficulty in determining a clear prevalence of sexual addiction may be related to the still poorly defined diagnostic criteria for this disorder as well as the choice of measurement tools.

In the inmate population, to our knowledge, there are no French prevalence studies of this disorder. In addition, no studies have been conducted to compare the prevalence of sexual addiction among sex offenders (SASO) with that among non-sex offenders (SANSO).

We hope that better screening for addiction would enable better management of patients with this disorder, promoting their psychosocial rehabilitation and well-being, so as to prevent the recurrence of a transition to sexual arousal.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–65 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Julien DA COSTA

Toulouse, 31000, France

Location status: Recruiting

Location contact

Julien JD Da Costa, MD

CONTACT

[email protected]

05 61 14 90 10 ext. +33

Julien JD Da Costa, MD

PRINCIPAL_INVESTIGATOR

About this study

This study is intended to assess the prevalence of sexual addiction among a population of detainees at the Muret detention center in Haute-Garonne.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male subjects
  • Detainees at Muret Detention Center
  • Aged between 18 and 65 at the time of the search
  • And having agreed to participate in the research.

Exclusion criteria

  • Person under legal protection, guardianship or curatorship ;
  • Insufficient command of the French language
  • Existence of cognitive disorders preventing a good understanding of the information relating to the study or the various questionnaires.

Treatment and study plan

semi-structured interviews

Other

semi-structured interview conducted by a psychiatrist

Primary outcomes

  1. The main objective is to determine the prevalence of sexual addiction among a population of men incarcerated at the Muret detention center in Haute-Garonne.

    Time frame: Day 1

    The primary endpoint is the presence of a patient's sexual addiction defined by a score greater than 13 on the Carnes screening test.

Secondary outcomes

  1. Determine the prevalence of sexual addiction in a population of sexual offenders

    Time frame: Day 1

    The distribution of the proportions of people with sexual addiction is defined by a score greater than 13 on the Carnes screening test in two population groups, perpetrators of sexual offenses and perpetrators of non-sexual offenses.

  2. Determine the prevalence of sexual addiction in a population of non-sexual offenders

    Time frame: Day 1

    The distribution of the proportions of people with sexual addiction is defined by a score greater than 13 on the Carnes screening test in two population groups, perpetrators of sexual offenses and perpetrators of non-sexual offenses.

  3. Compare the prevalence of sexual addiction in these two populations

    Time frame: Day 1

    The distribution of the proportions of people with sexual addiction is defined by a score greater than 13 on the Carnes screening test in two population groups, perpetrators of sexual offenses and perpetrators of non-sexual offenses.

  4. Determine any addictive and psychiatric co-morbidities associated with each population

    Time frame: Day 1

    The presence of psychiatric disorders based on medical file and the addictive disorders based tanks ASSIST Test (Alcohol, Smoking and Substance Involvement Screening Test).

Study contacts

Contact information is provided by the study sponsor or research team.

Julien JD Da Costa, MD

CONTACT

[email protected]

05 61 14 90 10 ext. +33

Sponsors and collaborators

Lead sponsor

Federation Regionale de Recherche en Psychiatrie et Sante Mentale Occitanie

Other

Registry information

Official study title

Prevalence of Sexual Addiction in an Inmate Population at the Muret Detention Center in Haute-Garonne.

Acronym: PAS-CD

Important dates

Study start
2023
Primary completion
2027
Study completion
2027
First posted
Aug 2, 2022
Registry last updated
Sep 2, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.